Peptides DB

Research-centric peptide and protocol reference hub

GLP-1 Blends

Research-centric overview

Share
Peptide

### Summary GLP-1 blends refer to combinations of glucagon-like peptide-1 (GLP-1) analogs or related compounds that may enhance the secretion of this hormone, which plays a critical role in glucose metabolism and appetite regulation. Recent research has explored various natural extracts and dietary components that may influence GLP-1 secretion and its physiological effects.

Community effect votes, structured logs, and side-effect summaries.

Effect profile (overview)

Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.

Effect profile (AI + community): Metabolic & appetite 5.0/5 · Skin & aesthetics 3.0/5Healing 0.0Muscle 0.0Metabolic 5.0Neuro 0.0Sleep 0.0Inflammation 0.0Skin 3.0

Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.

Research log summary heatmap

Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.

No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.

Anonymous side-effect patterns

Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.

No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.

Research footprint

Last analyzed Jun 2, 2026
5
Studies indexed
2
Human
0
Animal
5
AI analyzed
Evidence mix40% human · 0% animal · 40% cellular · 0% review
Highest phase: Preclinical onlyYears covered: 2023–2026
Librarian pulse — latest actionsFull changelog ↓
  • May 28, 6:01 AMRefreshedRefreshed content for GLP-1 Blends
  • May 27, 6:03 AMRefreshedRefreshed content for GLP-1 Blends
  • May 26, 2:29 PMtask_runCompleted task: Find real articles for GLP-1 Blends (thin literature)

Research & intelligence feed

Studies, clinical trials, community discussions, and news.

Effect of the Intake of Specific Formulas for Diabetes With Sucromalt and Isomaltulose on the Glycemic Index, Insulin, Glucagon-like Peptide-1, Gastric Inhibitory Peptide Levels and Subjective Appetite in Subjects With Type 2 DiabetesClinical TrialClinicalTrials.govPublished Sep 1, 2016Added May 27, 2026

This study evaluated the effects of specific formulas containing sucromalt and isomaltulose on glycemic index, insulin, GLP-1, GIP levels, and subjective appetite in subjects with type 2 diabetes. The exact doses and specific outcomes were not detailed in the abstract. The study aimed to provide insights into the metabolic effects of these formulas in a diabetic population.

Phase: NAStatus: COMPLETED
Effect of a New Optimized Plant Ingredient on the Plant Protein of Seniors at Cardio-metabolic Risk - P-Probs ProjectClinical TrialClinicalTrials.govPublished May 14, 2025Added May 27, 2026

Not reported in abstract.

Phase: NAStatus: NOT_YET_RECRUITING
A Randomized, Double-blind, Placebo-controlled, Crossover, Single-center, Proof of Concept Study to Evaluate the Efficacy of GoodIdea® on Glucose Homeostasis in a Healthy Population.Clinical TrialClinicalTrials.govPublished Apr 24, 2018Added May 27, 2026

This study evaluated the efficacy of GoodIdea® on glucose homeostasis in a healthy population. The study was a randomized, double-blind, placebo-controlled, crossover design. Not reported in abstract.

Phase: NAStatus: COMPLETED
A Double-Blind, Randomized Placebo-Controlled Study to Evaluate a Postbiotic Supplement in Supporting Weight Loss and Metabolic HealthClinical TrialClinicalTrials.govPublished May 2, 2025Added May 27, 2026

This study evaluated a postbiotic supplement for its effects on weight loss and metabolic health in participants. The specific dosage and duration of the intervention were not reported. The outcomes measured included various metabolic health parameters.

Phase: NAStatus: RECRUITING
Development of Rich & Creamy Melt® Organic Cooking Blend for Oxidative Stability and Reducing Childhood ObesityClinical TrialClinicalTrials.govPublished Oct 1, 2012Added Apr 16, 2026

The study evaluated the oxidative stability of the Rich & Creamy Melt® Organic Cooking Blend and its potential effects on childhood obesity. The specifics of the measured outcomes, including doses and populations, were not detailed in the abstract. The findings suggest a focus on the blend's properties rather than direct effects on obesity.

Phase: NAStatus: COMPLETED
Effect of a Dietary Supplement (FitLine TopShape) on the Incretin ResponseClinical TrialClinicalTrials.govPublished Oct 24, 2025Added Apr 16, 2026

This study evaluated the effect of a dietary supplement (FitLine TopShape) on the incretin response. The population, dosage, and specific outcomes measured were not detailed in the abstract. The findings regarding the supplement's impact on incretin levels remain unspecified.

Phase: NAStatus: ACTIVE_NOT_RECRUITING
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food IntakeClinical TrialClinicalTrials.govPublished Mar 21, 2017Added Apr 16, 2026

This study evaluated the effects of different protein sources on appetite control, satiety, and subsequent food intake. The specific protein sources and their doses were not reported in the abstract. The findings suggest variations in appetite responses based on protein source.

Phase: NAStatus: COMPLETED
AVANDIA CV Outcomes Study: Thiazolidinedione Intervention With Vitamin D Evaluation (TIDE) A Multicenter Randomized Double-Blind Placebo-Controlled Trial of a Thiazolidinedione or Placebo and of Vitamin D or Placebo In People With Type 2 Diabetes at Risk For Cardiovascular DiseaseClinical TrialClinicalTrials.govPublished May 1, 2009Added Apr 16, 2026

This study evaluated the cardiovascular outcomes of a thiazolidinedione (TZD) or placebo and vitamin D or placebo in individuals with type 2 diabetes at risk for cardiovascular disease. The study was multicenter, randomized, double-blind, and placebo-controlled. No therapeutic claims are made regarding the outcomes.

Phase: PHASE4Status: TERMINATED
Investigating the Effect of the Combination of L-carnitine Tartrate, Dihydrocapsiate and Protein Yeast Hydrolysate (DNF10) for 12 Weeks on Energy Intake and Energy Expenditure in Overweight and Obese Adults: A Randomised Controlled Trial- (SPICE)Clinical TrialClinicalTrials.govPublished Oct 30, 2024Added Apr 16, 2026

This study measured the effects of a combination of L-carnitine tartrate, dihydrocapsiate, and protein yeast hydrolysate (DNF10) on energy intake and energy expenditure in overweight and obese adults over 12 weeks. The study utilized a randomized controlled trial design. No therapeutic claims are made regarding the outcomes.

Phase: NAStatus: COMPLETED
Semantic Scholar search for GLP-1 BlendsStudySemanticScholarAdded Dec 12, 2025

Not reported in abstract.

Sequential Meals Containing Animal and Plant-Based Saturated Fats Have Differential Effects on Postprandial Gut Hormones but No Impact on Satiety Compared with Unsaturated Fats in Generally Healthy Males: Findings from the Randomized Controlled Crossover CocoHeart Study.StudyPubMedPublished Jan 1, 2023Added Dec 12, 2025

This study found that animal-based saturated fats increased postprandial GLP-1 levels more than unsaturated fats, while plant-based saturated fats increased PYY levels, but neither type affected satiety.

In Vitro Assessment of the Bioaccessibility and Hypoglycemic Properties of Essential Amino Acids Blend: Implication for Diabetes Management.StudyPubMedAdded Dec 12, 2025

Not reported in abstract.

Combination of Citrus aurantifolia Fruit Rind and Theobroma cacao Seed Extracts Stimulates Glucagon-Like Peptide-1 Secretion by Activating hTAS2Rs and the Phospholipase C-Mediated Signaling Pathway in NCI-H716 Cells.StudyPubMedAdded Dec 12, 2025

The combination of Citrus aurantifolia and Theobroma cacao extracts significantly increased GLP-1 secretion in NCI-H716 cells, but further research is needed to understand its implications for human health.

External databases

Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.

Community notes

No comments yet. Share research notes, citations, or observations below.

Comments appear immediately.

Community research logs (detail)

No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.

Anonymous side-effect reporting (detail)

This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.

Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.

Librarian Changelog

Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.

5d agoRefreshai-researcher85%

Refreshed content for GLP-1 Blends

6d agoRefreshai-researcher85%

Refreshed content for GLP-1 Blends

May 26task_runlibrarian-runner

Completed task: Find real articles for GLP-1 Blends (thin literature)

May 26Ingestiondiscovery

Searched for real articles on GLP-1 Blends

Apr 20Refreshdiscovery50%

Refreshed content for GLP-1 Blends

Apr 20SummarySemanticScholar0%

Auto-summarized study: "Semantic Scholar search for GLP-1 Blends..."